Patients who have been diagnosed with a head and/or neck cancer commonly develop oral mucositis (OM). The purpose of this study is to estimate the effect of Caphosol on OM and to evaluate if Caphosol had any effect on clinical outcomes which include quality of life, oral intake, swallowing function and pain.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
100
Oral Mouth Rinse
University of Florida College of Medicine
Gainesville, Florida, United States
RECRUITINGH. Lee Moffitt Cancer Center
Tampa, Florida, United States
RECRUITINGBeth Israel Medical Center
New York, New York, United States
The primary objective is to estimate ht incidence of OM in H&N cancer patients undergoing radiation therapy with or without chemotherapy and/or sensitizer who receive Caphosol.
Time frame: 15 weeks
The secondary objective of this study is to correlate components of OM data with clinical outcomes (pain, narcotic use, oral intake)
Time frame: 15 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Duke University Medical Center
Durham, North Carolina, United States
RECRUITINGTemple University Hospital
Philadelphia, Pennsylvania, United States
RECRUITINGMD Anderson Cancer Center
Houston, Texas, United States
RECRUITING